Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-alpha-1

Thymalfasin, Zadaxin, Thymosin α1

Quick Stats
Studies 759
Trials 63
Score 3
2025 pubmed

Thymosin α1 alleviates pulpitis by inhibiting ferroptosis of dental pulp cells.

Wu. Jie J; Gong. Qimei Q; Liu. Wenxuan W; Chen. Aijia A; Liao. Zekai Z; Huang. Yihua Y; Jiang. Wenkai W; Tong. Zhongchun Z

Key Findings

  • Single‑cell RNA‑seq revealed many ferroptosis‑related genes are altered in inflamed pulp tissue compared to healthy pulp.
  • Thymosin‑alpha‑1 increased GPX4 and ferritin (FTL) levels while decreasing inflammatory cytokines (TNF‑α, IL‑1β, IL‑6) and free iron in LPS‑stimulated dental pulp cells.
  • In rat models, delivering thymosin‑alpha‑1 (as a gelatin sponge or injection) reduced inflammatory cell infiltration, lowered PTGS2 expression, and restored GPX4 levels, indicating less ferroptosis and inflammation.

Practical Outcomes

  • For DIY health enthusiasts, thymosin‑alpha‑1 shows promise as a targeted therapy for pulpitis, but current evidence is limited to cell cultures and animal studies. No human dosing, safety, or delivery protocols are established yet, so it isn’t ready for self‑administration. If you suffer from recurrent pulp inflammation, discuss the possibility of thymosin‑alpha‑1 with a dental professional or researcher before considering off‑label use.

Summary

The study shows that the peptide thymosin‑alpha‑1 can protect dental pulp cells from a type of cell death called ferroptosis, which helps reduce inflammation and tissue damage in tooth pulpitis. In lab‑grown cells and rat teeth, adding thymosin‑alpha‑1 boosted protective proteins (like GPX4) and lowered inflammatory markers, suggesting it could be a useful treatment for painful tooth pulp inflammation.

Abstract

Tooth pulpitis is a prevalent oral disorder. Understanding the underlying mechanisms of pulpitis and developing effective treatment strategies hold great significance. Ferroptosis has recently emerged as a new form of cell death, but the role of ferroptosis in pulpitis remains largely unknown. In our study, single-cell RNA sequencing (scRNA-seq) was used to identify cellular heterogeneity between 3 pulpitis tissue and 3 healthy pulp tissue, and explored ferroptosis occurrence in pulpitis tissue and inflamed dental pulp cells (DPCs). In scRNA-seq, 40 231 cells (Pulpitis: 17 814; Healthy pulp: 22 417) were captured, and visualized into 12 distinct cell clusters. Differentially expressed ferroptosis-related genes (DE-FRGs) were almost presented in each cluster in pulpitis vs healthy pulp. ROS and Fe<sup>2+</sup> levels significantly rose, and immunohistochemistry showed low expression of GPX4 and high expression of PTGS2 in pulpitis. In LPS-stimulated DPCs, thymosin &#x3b1;1 increased the expression of GPX4 and FTL, and decreased expression of TNF-&#x3b1;, IL-1&#x3b2;, IL-6, and Fe<sup>2+</sup> levels. In rat pulpitis models, both prothymosin &#x3b1; (PTMA, precursor of thymosin &#x3b1;1) gelatin sponge placed at the hole of pulp (LPS-P(gs)) and PTMA injection in pulp (LPS-P(i)) significantly reduced infiltration of inflammatory cells and expression of PTGS2, and increased the expression of GPX4. In RNA sequencing, the expression of DE-FRGs were reversed when thymosin &#x3b1;1 were added in LPS-stimulated DPCs. Collectively, single-cell atlas reveals cellular heterogeneity between pulpitis and healthy pulp, and ferroptosis occurrence in pulpitis. Thymosin &#x3b1;1 may reduce ferroptosis in DPCs to alleviate pulpitis and thus potentially has the ability to treat pulpitis.

Study Information

Provider

pubmed

Year

2025

Date

2025-10-14T00:00:00.000Z

DOI

10.1038/s41368-025-00394-4

References

60